slotkoers
Bulgaria S.E.
00:00:00 29-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
17,4
BGN
|
+0,58%
|
|
-.--%
|
+2,35%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
649,8
|
896
|
1.141
|
1.259
|
1.360
|
1.510
|
Bedrijfswaarde
1 |
659,9
|
908
|
1.153
|
1.271
|
1.372
|
1.521
|
K/w-verhouding
|
54,8
x
|
273
x
|
3.381
x
|
746
x
|
469
x
|
444
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
17,1
x
|
25,5
x
|
28,5
x
|
29,7
x
|
31,7
x
|
31,1
x
|
Bedrijfswaarde/omzet
|
17,3
x
|
25,9
x
|
28,8
x
|
30
x
|
31,9
x
|
31,3
x
|
Bedrijfswaarde/EBITDA
|
41,9
x
|
136
x
|
251
x
|
227
x
|
211
x
|
246
x
|
Bedrijfswaarde/FCF
|
-180
x
|
1.315
x
|
91,3
x
|
1.499
x
|
-1.770
x
|
-631
x
|
FCF Yield
|
-0,55%
|
0,08%
|
1,1%
|
0,07%
|
-0,06%
|
-0,16%
|
Price to Book
|
6,91
x
|
9,25
x
|
11,8
x
|
12,7
x
|
13,4
x
|
14,4
x
|
Aantal aandelen (in duizenden)
|
88.800
|
88.800
|
88.800
|
88.800
|
88.800
|
88.800
|
Referentieprijs
2 |
7,318
|
10,09
|
12,85
|
14,18
|
15,32
|
17,00
|
Datum van publicatie
|
28/03/19
|
30/01/20
|
1/03/21
|
28/02/22
|
28/02/23
|
10/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
38,06
|
35,07
|
40,03
|
42,43
|
42,96
|
48,51
|
EBITDA
1 |
15,74
|
6,694
|
4,588
|
5,591
|
6,501
|
6,182
|
Bedrijfsresultaat (EBIT)
1 |
12,43
|
3,378
|
0,363
|
1,796
|
3,17
|
4,007
|
Operationele Marge
|
32,65%
|
9,63%
|
0,91%
|
4,23%
|
7,38%
|
8,26%
|
Resultaat voor belastingen (EBT)
1 |
12,42
|
3,059
|
0,554
|
1,899
|
3,251
|
3,868
|
Nettowinst (verlies)
1 |
11,2
|
2,845
|
0,344
|
1,667
|
2,901
|
3,398
|
Nettomarge
|
29,43%
|
8,11%
|
0,86%
|
3,93%
|
6,75%
|
7%
|
WPA
2 |
0,1334
|
0,0370
|
0,003800
|
0,0190
|
0,0327
|
0,0383
|
Free Cash Flow
1 |
-3,659
|
0,6905
|
12,62
|
0,848
|
-0,7751
|
-2,412
|
FCF-marge
|
-9,61%
|
1,97%
|
31,53%
|
2%
|
-1,8%
|
-4,97%
|
Kasstroomconversie (ebitda)
|
-
|
10,32%
|
275,14%
|
15,17%
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
24,27%
|
3.669,55%
|
50,87%
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
28/03/19
|
30/01/20
|
1/03/21
|
28/02/22
|
28/02/23
|
10/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
10,1
|
12
|
12
|
11,8
|
11,7
|
11,1
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
0,6432
x
|
1,789
x
|
2,613
x
|
2,116
x
|
1,794
x
|
1,796
x
|
Free Cash Flow
1 |
-3,66
|
0,69
|
12,6
|
0,85
|
-0,78
|
-2,41
|
ROE (netto-inkomsten/eigen vermogen)
|
12,7%
|
2,98%
|
0,36%
|
1,7%
|
2,89%
|
3,29%
|
ROA (netto-inkomsten/totale activa)
|
7,47%
|
1,85%
|
0,19%
|
0,96%
|
1,67%
|
2,07%
|
Totale activa
1 |
150
|
153,4
|
177,9
|
173,6
|
173,6
|
164,4
|
Nettoactief per aandeel
2 |
1,060
|
1,090
|
1,090
|
1,110
|
1,150
|
1,180
|
Cashflow per aandeel
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
1 |
1,4
|
0,99
|
2,82
|
1,57
|
1,58
|
1,91
|
Capex/omzet
|
3,68%
|
2,82%
|
7,04%
|
3,71%
|
3,68%
|
3,94%
|
Datum van publicatie
|
28/03/19
|
30/01/20
|
1/03/21
|
28/02/22
|
28/02/23
|
10/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +2,35% | 844 mln. | | +20,61% | 43,18 mld. | | +20,67% | 22,59 mld. | | +14,56% | 14,56 mld. | | +13,94% | 13,54 mld. | | +43,35% | 11,5 mld. | | -8,37% | 6,93 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +10,21% | 5,36 mld. |
Generieke geneesmiddelen
|